ChoA Pharmaceutical Co.Ltd (034940) — Capital Reinvestment Ratio
Latest as of September 2025:
0.26x
ChoA Pharmaceutical Co.Ltd (034940) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.26 Billion) in capital expenditures (₩324.67 Million). See cash generation quality of ChoA Pharmaceutical Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.26 Billion
KRW
Capital Expenditures
₩324.67 Million
KRW
Data as of
Sep 2025
Most recent filing
ChoA Pharmaceutical Co.Ltd Capital Reinvestment Ratio (2004–2020)
This chart tracks ChoA Pharmaceutical Co.Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd (2004–2020)
Year-by-year Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd from 2004 to 2020. For live market cap and broader valuation context, see 034940 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.87x | ₩1.92 Billion | ₩3.60 Billion | ▲ +460.2% |
| 2019 | 0.33x | ₩4.16 Billion | ₩1.39 Billion | ▼ -65.4% |
| 2018 | 0.96x | ₩2.04 Billion | ₩1.97 Billion | ▼ -60.9% |
| 2016 | 2.47x | ₩930.42 Million | ₩2.30 Billion | ▲ +64.4% |
| 2015 | 1.50x | ₩1.19 Billion | ₩1.78 Billion | ▼ -83.3% |
| 2014 | 9.02x | ₩625.52 Million | ₩5.64 Billion | ▲ +2884.8% |
| 2013 | 0.30x | ₩3.53 Billion | ₩1.07 Billion | ▲ +110.8% |
| 2004 | 0.14x | ₩3.57 Billion | ₩512.47 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow